Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3754017014 | Product containing galcanezumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3754018016 | Galcanezumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
1175141000172118 | produit contenant du galcanézumab sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
1183211000172118 | product dat galcanezumab in parenterale vorm bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing galcanezumab in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
Product containing galcanezumab in parenteral dose form (medicinal product form) | Is a | Galcanezumab-containing product | true | Inferred relationship | Some | ||
Product containing galcanezumab in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
Product containing galcanezumab in parenteral dose form (medicinal product form) | Has active ingredient | Galcanezumab | true | Inferred relationship | Some | 1 | |
Product containing galcanezumab in parenteral dose form (medicinal product form) | Plays role | Antimigraine therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only galcanezumab in parenteral dose form (medicinal product form) | Is a | True | Product containing galcanezumab in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets